Xavier Monzonís1, Edurne Arriola2. Show Affiliations » 1. Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain. 2. Medical Oncology Department, Hospital del Mar-CIBERONC, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain. Electronic address: earriola@parcdesalutmar.cat.
Abstract
Entities: Disease Species
Mesh： See more » Adenocarcinoma of Lung/drug therapyAdenocarcinoma of Lung/enzymologyAdenocarcinoma of Lung/geneticsAdenocarcinoma of Lung/pathologyAnaplastic Lymphoma Kinase/antagonists & inhibitorsAnaplastic Lymphoma Kinase/geneticsFemaleHumansLactams, Macrocyclic/adverse effectsLactams, Macrocyclic/therapeutic useLung Neoplasms/drug therapyLung Neoplasms/enzymologyLung Neoplasms/geneticsLung Neoplasms/pathologyMiddle AgedOrganophosphorus Compounds/adverse effectsOrganophosphorus Compounds/therapeutic usePneumonia/chemically inducedPneumonia/pathologyPrognosisPyrimidines/adverse effectsPyrimidines/therapeutic use
Substances： See more » Lactams, MacrocyclicOrganophosphorus CompoundsPyrimidinesALK protein, humanAnaplastic Lymphoma Kinasebrigatiniblorlatinib
Year: 2019 PMID： 31668321 DOI： 10.1016/j.jtho.2019.06.013
Source DB: PubMed Journal: J Thorac Oncol ISSN： 1556-0864 Impact factor: 15.609